FSWCX
Price
$13.00
Change
+$0.09 (+0.70%)
Updated
Sep 26 closing price
Net Assets
6.2B
VVIAX
Price
$72.77
Change
+$0.60 (+0.83%)
Updated
Sep 26 closing price
Net Assets
202.84B
Interact to see
Advertisement

FSWCX vs VVIAX

Header iconFSWCX vs VVIAX Comparison
Open Charts FSWCX vs VVIAXBanner chart's image
Fidelity SAI US Value Index
Price$13.00
Change+$0.09 (+0.70%)
VolumeN/A
Net Assets6.2B
Vanguard Value Index Adm
Price$72.77
Change+$0.60 (+0.83%)
VolumeN/A
Net Assets202.84B
FSWCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSWCX vs. VVIAX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSWCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. FSWCX (6.2B). VVIAX pays higher dividends than FSWCX: VVIAX (2.10) vs FSWCX (1.78). FSWCX was incepted earlier than VVIAX: FSWCX (8 years) vs VVIAX (25 years). FSWCX (0.11) is less costly to investors than VVIAX (0.05). FSWCX is a more actively managed with annual turnover of: 63.00 vs. VVIAX (9.00). FSWCX has a lower initial minimum investment than VVIAX: FSWCX (0) vs VVIAX (3000). FSWCX annual gain was more profitable for investors over the last year : 9.22 vs. VVIAX (7.68). VVIAX (81.82) and FSWCX (78.53) have equivalent 5 years return.
FSWCXVVIAXFSWCX / VVIAX
Total Expense Ratio0.110.05220%
Annual Report Gross Expense Ratio0.110.05220%
Fund Existence8 years25 years-
Gain YTD10.54110.243103%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.2B203B3%
Annual Yield % from dividends1.782.1085%
Returns for 1 year9.227.68120%
Returns for 3 years49.6250.2599%
Returns for 5 years78.5381.8296%
Returns for 10 yearsN/A147.68-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MEDP496.798.84
+1.81%
Medpace Holdings
TATT40.020.20
+0.50%
TAT Technologies Ltd
BLTE69.98-0.03
-0.04%
Belite Bio
ENSC2.24-0.02
-0.88%
Ensysce Biosciences
PBHC15.32-0.28
-1.82%
Pathfinder Bancorp